Endocrine and metabolic agents - Preface

被引：0

|

作者：

Wagman, AS

Cody, WL

机构：

[1] Chiron Corp, Small Mol Drug Discovery, Emeryville, CA 94608 USA

[2] Pfizer Inc, Ann Arbor, MI 48106 USA

来源：

CURRENT PHARMACEUTICAL DESIGN | 2004年 / 10卷 / 28期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页数：2

相关论文

共 50 条

[1] Endocrine and metabolic agents - Preface
Roth, BD
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (04) : U2 - U2
[2] Endocrine and metabolic agents - Preface
Sliskovic, DR
Roth, BD
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (01) : U2 - U3
[3] Endocrine and metabolic agents - Preface
Roth, BD
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 1999, 5 (09) : U2 - U2
[4] Endocrine and metabolic agents - Preface
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 1999, 5 (01) : U2 - U2
[5] Endocrine and metabolic agents - Preface
Roth, BD
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (06) : U2 - U2
[6] Endocrine and metabolic agents - Preface
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 1998, 4 (01) : U2 - U2
[7] Endocrine and metabolic agents - Preface
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (01) : U2 - U3
[8] Endocrine, metabolic and immunological agents - Preface
Wagman, AS
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (14)
[9] Endocrine, metabolic and immunological agents - Preface
Wagman, AS
Cody, WL
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (15)
[10] Immunology, endocrine and metabolic agents - Preface
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 1997, 3 (01) : U2 - U3

← 1 2 3 4 5 →